Drug Shortage Report for MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
Report ID | 47356 |
Drug Identification Number | 02461412 |
Brand name | MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE |
Common or Proper name | EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | EFAVIRENZ TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE |
Strength(s) | 600MG 300MG 200MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 BT |
ATC code | J05AR |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2019-06-11 |
Actual start date | |
Estimated end date | 2019-06-21 |
Actual end date | 2019-06-18 |
Shortage status | Resolved |
Updated date | 2019-06-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v64 | 2019-06-19 | English | Compare |
v63 | 2019-06-18 | French | Compare |
v62 | 2019-06-18 | English | Compare |
v61 | 2019-06-12 | English | Compare |
v60 | 2019-06-04 | French | Compare |
v59 | 2019-06-04 | English | Compare |
v58 | 2019-05-28 | French | Compare |
v57 | 2019-05-28 | English | Compare |
v56 | 2019-05-28 | French | Compare |
v55 | 2019-05-28 | English | Compare |
v54 | 2019-05-28 | English | Compare |
v53 | 2019-05-22 | French | Compare |
v52 | 2019-05-22 | English | Compare |
v51 | 2019-05-14 | French | Compare |
v50 | 2019-05-14 | English | Compare |
v49 | 2019-04-10 | French | Compare |
v48 | 2019-04-10 | English | Compare |
v47 | 2019-04-03 | French | Compare |
v46 | 2019-04-03 | English | Compare |
v45 | 2019-03-28 | French | Compare |